I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| fibroblast | 6 studies | 28% ± 9% | |
| myofibroblast cell | 5 studies | 19% ± 2% | |
| pericyte | 5 studies | 30% ± 16% | |
| smooth muscle cell | 5 studies | 16% ± 1% | |
| conventional dendritic cell | 4 studies | 28% ± 6% | |
| connective tissue cell | 4 studies | 27% ± 11% | |
| endothelial cell | 4 studies | 24% ± 14% | |
| macrophage | 4 studies | 26% ± 7% | |
| natural killer cell | 4 studies | 23% ± 10% | |
| plasmacytoid dendritic cell | 4 studies | 28% ± 8% | |
| hematopoietic precursor cell | 3 studies | 25% ± 6% | |
| non-classical monocyte | 3 studies | 25% ± 5% | |
| platelet | 3 studies | 19% ± 3% | |
| ciliated cell | 3 studies | 18% ± 0% | |
| CD8-positive, alpha-beta T cell | 3 studies | 24% ± 10% | |
| basal cell | 3 studies | 33% ± 9% | |
| dendritic cell | 3 studies | 34% ± 7% |
